Idexx Laboratories | IDXX - Operating Profit

Stock Price
644.02
Daily Change
1.08 0.17%
Monthly
-8.89%
Yearly
39.83%
Q1 Forecast
649.81

Idexx Laboratories reported $315.6M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Align Technology USD 224.71M 40.06M Dec/2025
Dentsply International USD 512M 401M Sep/2025
Dexcom USD 242.5M 29.9M Sep/2025
Edwards Lifesciences USD 425.1M 5.8M Sep/2025
Fujifilm JPY 83.2B 7.9B Sep/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Henry Schein USD 198M 22M Sep/2025
Hologic USD 237M 16M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Neogen USD -5.38M 10.71M Sep/2025
ResMed USD 497.6M 35.25M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Steris USD 278M 7.1M Dec/2025
Tandem Diabetes Care USD -22.86M 9M Sep/2025
Teleflex USD -408.9M 586.38M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Zoetis USD 936M 63M Sep/2025